|
1
|
Pisani P, Parkin DM, Bray F and Ferlay J:
Estimates of the worldwide mortality from 25 cancers in 1990. Int J
Cancer. 83:18–29. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Laversanne M, Brewster
DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E,
Swaminathan R, Antoni S, et al: Cancer Incidence in five
continents: Inclusion criteria, highlights from volume X and the
global status of cancer registration. Int J Cancer. 137:2060–2071.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ando N, Kato H, Igaki H, Shinoda M, Ozawa
S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic
significance of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in oncologic outcomes of esophageal
cancer: A systematic review and meta-analysis. Ann Surg Oncol.
23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C,
Jin Y, Zhou YX, Wang DS, He MM, Bai L, et al: A novel
inflammation-based prognostic score in esophageal squamous cell
carcinoma: The C-reactive protein/albumin ratio. BMC Cancer.
15:3502015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimada H, Takiguchi N, Kainuma O, Soda H,
Ikeda A, Cho A, Miyazaki A, Gunji H, Yamamoto H and Nagata M: High
preoperative neutrophil-lymphocyte ratio predicts poor survival in
patients with gastric cancer. Gastric Cancer. 13:170–176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sarraf KM, Belcher E, Raevsky E, Nicholson
AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its
association with survival after complete resection in non-small
cell lung cancer. J Thorac Cardiovasc Surg. 137:425–428. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagata T, Nakase Y, Nakamura K, Sougawa A,
Mochiduki S, Kitai S and Inaba S: Prognostic impact of a
nutritional index including muscle volume in stage 4 colorectal
cancer. In Vivo. 30:885–891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H and Matsushima M:
The C-reactive protein/albumin ratio, a novel inflammation-based
prognostic score, predicts outcomes in patients with hepatocellular
carcinoma. Ann Surg Oncol. 22:803–810. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishibashi Y, Tsujimoto H, Hiraki S, Kumano
I, Yaguchi Y, Horiguchi H, Nomura S, Ito N, Shinto E, Aosasa S, et
al: Prognostic value of preoperative systemic immunoinflammatory
measures in patients with esophageal cancer. Ann Surg Oncol.
25:3288–3299. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. John Wiley
& Sons; 2016
|
|
13
|
Tsujimoto H, Hiraki S, Takahata R, Nomura
S, Ito N, Kanematsu K, Horiguchi H, Aosasa S, Yamamoto J and Hase
K: Laparoscopic jejunostomy for obstructing upper gastrointestinal
malignancies. Mol Clin Oncol. 3:1307–1310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hiraoka A, Aibiki T, Okudaira T, Toshimori
A, Kawamura T, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y,
et al: Muscle atrophy as pre-sarcopenia in Japanese patients with
chronic liver disease: Computed tomography is useful for
evaluation. J Gastroenterol. 50:1206–1213. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsujimoto H, Takahata R, Nomura S, Yaguchi
Y, Kumano I, Matsumoto Y, Yoshida K, Horiguchi H, Hiraki S, Ono S,
et al: Video-assisted thoracoscopic surgery for esophageal cancer
attenuates postoperative systemic responses and pulmonary
complications. Surgery. 151:667–673. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsujimoto H, Ono S, Sugasawa H, Ichikura
T, Yamamoto J and Hase K: Gastric tube reconstruction by
laparoscopy-assisted surgery attenuates postoperative systemic
inflammatory response after esophagectomy for esophageal cancer.
World J Surg. 34:2830–2836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu XL, Yu HQ, Hu W, Song Q and Mao WM: A
Novel inflammation-based prognostic score, the C-reactive
protein/albumin ratio predicts the prognosis of patients with
operable esophageal squamous cell carcinoma. PLoS One.
10:e01386572015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duan H, Zhang X, Wang FX, Cai MY, Ma GW,
Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, et al: Prognostic role of
neutrophil-lymphocyte ratio in operable esophageal squamous cell
carcinoma. World J Gastroenterol. 21:5591–5597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sato H, Tsubosa Y and Kawano T:
Correlation between the pretherapeutic neutrophil to lymphocyte
ratio and the pathologic response to neoadjuvant chemotherapy in
patients with advanced esophageal cancer. World J Surg. 36:617–622.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng JF, Huang Y and Chen QX: Preoperative
platelet lymphocyte ratio (PLR) is superior to neutrophil
lymphocyte ratio (NLR) as a predictive factor in patients with
esophageal squamous cell carcinoma. World J Surg Oncol. 12:582014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J,
Pan H, Wang C, Zhou W and Liu X: Peripheral inflammation/immune
indicators of chemosensitivity and prognosis in breast cancer
patients treated with neoadjuvant chemotherapy. Onco Targets Ther.
11:1423–1432. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lorente D, Mateo J, Templeton AJ,
Zafeiriou Z, Bianchini D, Ferraldeschi R, Bahl A, Shen L, Su Z,
Sartor O and de Bono JS: Baseline neutrophil-lymphocyte ratio (NLR)
is associated with survival and response to treatment with
second-line chemotherapy for advanced prostate cancer independent
of baseline steroid use. Ann Oncol. 26:750–755. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Graziano V, Grassadonia A, Iezzi L, Vici
P, Pizzuti L, Barba M, Quinzii A, Camplese A, Di Marino P, Peri M,
et al: Combination of peripheral neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio is predictive of pathological complete
response after neoadjuvant chemotherapy in breast cancer patients.
Breast. 44:33–38. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Konishi H, Fujiwara H, Shiozaki A,
Hiramoto H, Kosuga T, Komatsu S, Ichikawa D, Okamoto K and Otsuji
E: Effects of neutropenia and histological responses in esophageal
squamous cell carcinoma with neo-adjuvant chemotherapy. Int J Clin
Oncol. 21:95–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eryilmaz MK, Mutlu H, Salim DK, Musri FY,
Tural D and Coskun HS: The neutrophil to lymphocyte ratio has a
high negative predictive value for pathologic complete response in
locally advanced breast cancer patients receiving neoadjuvant
chemotherapy. Asian Pac J Cancer Prev. 15:7737–7740. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schuell B, Gruenberger T, Kornek GV,
Dworan N, Depisch D, Lang F, Schneeweiss B and Scheithauer W: Side
effects during chemotherapy predict tumour response in advanced
colorectal cancer. Br J Cancer. 93:744–748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saarto T, Blomqvist C, Rissanen P, Auvinen
A and Elomaa I: Haematological toxicity: A marker of adjuvant
chemotherapy efficacy in stage II and III breast cancer. Br J
Cancer. 75:301–305. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee Y, Kim SH, Han JY, Kim HT, Yun T and
Lee JS: Early neutrophil-to-lymphocyte ratio reduction as a
surrogate marker of prognosis in never smokers with advanced lung
adenocarcinoma receiving gefitinib or standard chemotherapy as
first-line therapy. J Cancer Res Clin Oncol. 138:2009–2016. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taguchi S, Akamatsu N, Nakagawa T, Gonoi
W, Kanatani A, Miyazaki H, Fujimura T, Fukuhara H, Kume H and Homma
Y: Sarcopenia evaluated using the skeletal muscle index is a
significant prognostic factor for metastatic urothelial carcinoma.
Clin Genitourin Cancer. 14:237–243. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meza-Junco J, Montano-Loza AJ, Baracos VE,
Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR and Sawyer
MB: Sarcopenia as a prognostic index of nutritional status in
concurrent cirrhosis and hepatocellular carcinoma. J Clin
Gastroenterol. 47:861–870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Motoyama S, Sato Y, Wakita A,
Kawakita Y, Saito H and Minamiya Y: Decreased skeletal muscle mass
after neoadjuvant therapy correlates with poor prognosis in
patients with esophageal cancer. Anticancer Res. 36:6677–6685.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nagata K, Tsujimoto H, Nagata H, Harada M,
Ito N, Kanematsu K, Nomura S, Horiguchi H, Hiraki S, Hase K, et al:
Impact of reduced skeletal muscle volume on clinical outcome after
esophagectomy for esophageal cancer: A retrospective study.
Medicine (Baltimore). 97:e114502018. View Article : Google Scholar : PubMed/NCBI
|
